Jump to content
Sclero Forums
Sign in to follow this  

A Study of the Safety and Tolerability of MEDI-551 in Scleroderma

Recommended Posts

A Study of the Safety and Tolerability of MEDI-551 in Scleroderma.


The primary objective of this study is to evaluate the safety and tolerability of intravenously administered MEDI-551 over escalating single doses in adult subjects with Scleroderma. Identifier NCT00946699. Clinicaltrials.gov. This study is currently recruiting participants. (Also see: Clinical Trials)


These items were posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.

Janey Willis

ISN Support Specialist

(Retired) ISN Assistant Webmaster

(Retired) ISN News Director

(Retired) ISN Technical Writer for Training Manuals

International Scleroderma Network (ISN)

Share this post

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this